Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection

Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection

We described the long-term decay of neutralizing antibody (NtAb) to the wild-type and Delta SARS-CoV-2 variant after three antigen stimulations (mild or asymptomatic natural infection followed by two doses of the BNT162b2 mRNA vaccine after a median of 296 days) in immunocompetent healthcare workers...

Full description

Bibliographic Details
Main Authors: Ilaria Vicenti, Monica Basso, Filippo Dragoni, Francesca Gatti, Renzo Scaggiante, Lia Fiaschi, Saverio G. Parisi, Maurizio Zazzi
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
COVID-19
vaccination
Delta
BNT162b2 vaccine
neutralizing antibody
Online Access:https://www.mdpi.com/2076-393X/10/4/580

Internet

https://www.mdpi.com/2076-393X/10/4/580

Similar Items